Cargando…
Elevated Circulating Fibrocytes Is a Marker of Left Atrial Fibrosis and Recurrence of Persistent Atrial Fibrillation
BACKGROUND: In atrial fibrillation (AF), a more extensively fibrotic left atrium (LA) provides a substrate for arrhythmias and increases risk of relapse following ablation. Fibrocytes are bone marrow–derived circulating mesenchymal progenitors that have been identified in the atrium of patients with...
Autores principales: | Liu, Yang, Niu, Xiao‐Hui, Yin, Xiaomeng, Liu, Yue‐Jian, Han, Chao, Yang, Jie, Huang, Xin, Yu, Xiaohong, Gao, Lianjun, Yang, Yan‐Zong, Xia, Yun‐Long, Li, Hui‐Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907563/ https://www.ncbi.nlm.nih.gov/pubmed/29535140 http://dx.doi.org/10.1161/JAHA.117.008083 |
Ejemplares similares
-
Role of Circulating Fibrocytes in Cardiac Fibrosis
por: Lin, Rong-Jie, et al.
Publicado: (2016) -
Effect of Left Atrial Appendage Closure in Combination With Catheter Ablation on Left Atrial Function for Persistent Atrial Fibrillation
por: Yang, Jing, et al.
Publicado: (2021) -
Left Atrial Dysfunction, Fibrosis and the Risk of Thromboembolism in Patients With Paroxysmal and Persistent Atrial Fibrillation
por: Kim, Hee-Dong, et al.
Publicado: (2022) -
Circulating Soluble Suppression of Tumorigenicity 2 Predicts Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation
por: Tan, Ruopeng, et al.
Publicado: (2021) -
Safety and efficacy of catheter ablation in atrial fibrillation patients with left ventricular dysfunction
por: Long, Songbing, et al.
Publicado: (2019)